dc.contributor.author | Vojtěchová, Zuzana | |
dc.contributor.author | Milt, Petr | |
dc.contributor.author | Saláková, Martina | |
dc.contributor.author | Šmahelová, Jana | |
dc.contributor.author | Lohynská, Radka | |
dc.contributor.author | Lacek, Michal | |
dc.contributor.author | Čoček, Aleš | |
dc.contributor.author | Krátká, Zuzana | |
dc.contributor.author | Tachezy, Ruth | |
dc.date.accessioned | 2025-01-15T13:10:55Z | |
dc.date.available | 2025-01-15T13:10:55Z | |
dc.date.issued | 2024 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/2814 | |
dc.description.abstract | R42 Anotace anglickyThe clinical utility of liquid biopsies as diagnostic, predictive and prognostic biomarkers has been shown for several cancers. Our study analyses the dynamics of human papillomavirus (HPV) cell cell-free DNA (cfDNA) levels during the surveillance of patients with oropharyngeal tumours to improve patient management. Here, we present preliminary data on the evaluation of plasma collection methods, and their use in subsequent analyses of the dynamics of HPV cfDNA levels | en |
dc.language.iso | en | |
dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.title | The biomolecular markers for the personalized prediction of the treatment effect in patients with head and neck cancer: pilot study | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
dc.date.updated | 2025-01-15T13:10:55Z | |
dc.subject.keyword | HPV cfDNA | en |
dc.subject.keyword | tumour | en |
dc.subject.keyword | plasma | en |
dc.publisher.publicationPlace | Edinburgh | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
dc.date.embargoStartDate | 2025-01-15 | |
dc.contributor.organizer | Kenes Group | |
dc.type.obd | 110 | |
dc.type.version | info:eu-repo/semantics/acceptedVersion | |
dc.identifier.obd | 657724 | |
dc.subject.rivPrimary | 30000::30200::30204 | |
dc.subject.rivSecondary | 10000::10600::10607 | |
dcterms.isPartOf.journalYear | 2024 | |
uk.faculty.primaryId | 115 | |
uk.faculty.primaryName | Přírodovědecká fakulta | cs |
uk.faculty.primaryName | Faculty of Science | en |
uk.department.primaryId | 1034 | |
uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
uk.department.primaryName | Department of Genetics and Microbiology | en |
uk.event.name | 36th International Papillomavirus Conference - IPVC 2024 | |
dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v elektronické podobě | cs |
dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in e-form | en |
dc.type.obdHierarchyCode | 110::130::136 | en |
uk.displayTitle | The biomolecular markers for the personalized prediction of the treatment effect in patients with head and neck cancer: pilot study | en |